Immunology
News
- +
Argy-bargy continues at Avexa 27/08/2010 15:28:00
Major shareholder Calzada calls for EGM in SeptemberTroubled HIV drug developer Avexa may be poised for yet another coup after major shareholder Caldaza this week called for an extraordinary general meeting to discuss the future of the company - +
Monash University professor receives GSK Australia Award for Research 18/08/2010 09:38:00
Professor Charles Mackay receives $60,000 to further research on immunology and inflammationThis year’s prestigious GlaxoSmithKline Australia Award for Research has gone to Monash University’s Professor Charles Mackay for his work on immunology and inflammation, particularly the discovery of GPR43 as a major regulator of innate and inflammatory response. - +
Feature: Xenotransplantation offers hope to diabetes sufferers 16/08/2010 15:33:00
A xenotransplantation technology using insulin producing cells from pigs offers new hope for diabetes sufferers.Back when Living Cell Technologies's (LCT) current Medical Director and Founder, Professor Bob Elliott, was working in his Auckland clinic, he decided that the treatments available for patients with Type I diabetes simply weren't good enough. - +
Garvan researchers overturn T cell “dogma” 16/08/2010 15:24:00
Researchers from the Garvan Institute have challenged the prevailing "dogma" concerning the origin and function of a particular type of T cell that is central to immune function.Researchers from Sydney's Garvan Institute have challenged the dominant view in immunology circles as to how a special type of immune cell, called a T follicular helper cell (Tfh), is generated. - +
Monash names Professor Scott O’Neill as new science Dean 13/08/2010 14:34:00
University to become new home to world leading dengue fever projectMonash University has announced the appointment of esteemed Australian scientist and medical researcher Professor Scott O’Neill as the University’s new Dean of Science. - +
Generics to shrink allergic rhinitis market 20 percent by 2019: Datamonitor 05/08/2010 13:13:00
Recent developments in immunotherapy segment presenting new opportunitiesThe world market for treatments addressing allergic rhinitis will shrink by 20 percent to $US4 billion over the next 10 years as increasing numbers of generic products come to market, according to industry analysts Datamonitor. - +
Feature: Hunting for a hepatitis vaccine 04/08/2010 10:35:00
Understanding how the immune system responds to hepatitis C is crucial in developing a vaccine. An ongoing study by Andrew Lloyd and his team is hoping to shed light on this virus and its weaknesses.Professor Andrew Lloyd of the University of New South Wales is one of the central figures in the HITS study (Hepatitis C Incidence and Transmission Study) is a long-term prospective cohort study of eligible prison inmates in NSW. Lloyd’s cohort comprises high-risk, uninfected injecting drug users, who are followed at regular intervals longitudinally. - +
Link between HIV drugs and heart attack 30/07/2010 17:32:00
Study suggests greater heart attack risk associated with protease as opposed to integrase inhibitorsA study by Sydney researchers showing that the protease inhibitor type of HIV drugs carry a greater risk of heart attack than the new integrase inhibitor family of drugs is expected to have major implications for the future direction of treatment. - +
Australian Life Scientist July/August edition out now 28/07/2010 15:36:00
The Human Proteome Organisation (HPUO) 2010 World Congress and the Human Proteome Project feature in this issue, along with proteomics, synthetic biology, genetics and genomics, and next generation genome sequencing.The July/August edition of Australian Life Scientist is out now. The issue takes an in-depth look at the happenings at the upcoming Human Proteome Organisation (HPUO) 2010 World Congress, which will host the launch of the long awaited Human Proteome Project. - +
Athlomics launches biomarker test for sepsis 20/07/2010 10:57:00
Brisbane-based Athlomics provides first SeptiCyte Lab diagnostic kits to Brisbane’s Mater Pathology.Brisbane-based molecular diagnostics company, Athlomics, has provided the first of its SeptiCyte Lab kits for the diagnosis of sepsis to Brisbane’s Mater Pathology.
Interviews
- +
2010: a Sydney Project 23/05/2008 12:18:00
The Sydney Project aims to have human embryonic stem cells in clinical trials to treat type 1 diabetes in four years.The Sydney Project aims to have human embryonic stem cells in clinical trials to treat type 1 diabetes in four years.
Market Reports
- +
Biotech Market Spotlight: Patrys & CSL 28/01/2010 12:16:00
Collaboration between Patrys and CSL sends Patrys stocks soaring.Collaboration between Patrys and CSL sends Patrys stocks soaring.
Additional Resources
Newsletter Subscription
AMD Brings Next-Generation HD Gaming and Multimedia Features to the Mainstream 2010-01-20 15:20:00+11
Kingston Digital to Replace Affected Secure USB Flash Drives with Upgraded Security Architecture, New Drives 2010-01-19 16:00:00+11
MEDIA ALERT: NETAPP AUSTRALIA LEADS STORAGE MARKET IN Q3 FOR CAPACITY 2010-01-18 13:43:00+11
Aussie Device to Monitor Broadband 2010-01-18 12:40:00+11
VISION Pro Technology from AMD Gives Businesses the Competitive Advantage of Powerful and Responsive Visual Computing 2010-01-14 17:50:00+11
Biotechnology Directory
Jobs
- Laboratory Technician31/08/2010
Other
Science
Our client urgently needs an experienced and qualified lab-tech to start ASAP. - Senior Environmental Scientist26/08/2010
Other
Science
Are you an experienced and passionate environmental scientist? - Senior Environmental Scientist- EIA26/08/2010
Other
Science
Are you an experienced and passionate environmental scientist? - Laboratory Technician25/08/2010
Other
Science
Seeking suitably qualified Laboratory Technicians to join one of Australia's leading mining companies in the Northern Goldfields Region. - CHEMICALS: TECHNICAL SALES EXECUTIVE - $55K BASE + CAR ALLOWANCE23/08/2010
Other
Science
Chemicals, Lubricants, Cleaning Products - Autonomous & Highly Varied Role - Have Lunch at the Beach Each Day!!
Good Gear Guide
Computerworld
CIO
ARN

